RACC (RACC) is a publicly traded the market company. As of May 20, 2026, RACC trades at $10.32 with a market cap of $0 and a P/E ratio of 0.00. RACC moved +0.00% today. Year to date, RACC is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces RACC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Research Alliance III Prices $75M IPO, Lists 7.5M Shares at $10: Research Alliance III priced its $75 million IPO of 7,500,000 Class A shares at $10.00 each, listing on Nasdaq Capital Market under RACC on May 20, 2026, with closing expected May 21. The SPAC, led by CEO Matthew Hammond and CBO/COO Henry Stusnick, will pursue healthcare sector business combinations.
| Metric | Value |
|---|---|
| Price | $10.32 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 443.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
RACC analyst coverage data. Average price target: $0.00.